1. Home
  2. HAE vs MQ Comparison

HAE vs MQ Comparison

Compare HAE & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • MQ
  • Stock Information
  • Founded
  • HAE 1971
  • MQ 2010
  • Country
  • HAE United States
  • MQ United States
  • Employees
  • HAE N/A
  • MQ N/A
  • Industry
  • HAE Medical/Dental Instruments
  • MQ Computer Software: Prepackaged Software
  • Sector
  • HAE Health Care
  • MQ Technology
  • Exchange
  • HAE Nasdaq
  • MQ Nasdaq
  • Market Cap
  • HAE 3.3B
  • MQ 2.7B
  • IPO Year
  • HAE 1991
  • MQ 2021
  • Fundamental
  • Price
  • HAE $51.35
  • MQ $5.80
  • Analyst Decision
  • HAE Buy
  • MQ Hold
  • Analyst Count
  • HAE 10
  • MQ 13
  • Target Price
  • HAE $84.20
  • MQ $5.98
  • AVG Volume (30 Days)
  • HAE 901.8K
  • MQ 3.5M
  • Earning Date
  • HAE 11-06-2025
  • MQ 11-03-2025
  • Dividend Yield
  • HAE N/A
  • MQ N/A
  • EPS Growth
  • HAE 46.89
  • MQ N/A
  • EPS
  • HAE 3.28
  • MQ N/A
  • Revenue
  • HAE $1,346,046,000.00
  • MQ $553,223,000.00
  • Revenue This Year
  • HAE N/A
  • MQ $21.16
  • Revenue Next Year
  • HAE $6.50
  • MQ $21.56
  • P/E Ratio
  • HAE $15.60
  • MQ N/A
  • Revenue Growth
  • HAE 0.91
  • MQ 17.47
  • 52 Week Low
  • HAE $50.68
  • MQ $3.37
  • 52 Week High
  • HAE $94.99
  • MQ $7.04
  • Technical
  • Relative Strength Index (RSI)
  • HAE 27.41
  • MQ 38.75
  • Support Level
  • HAE $53.10
  • MQ $5.80
  • Resistance Level
  • HAE $54.52
  • MQ $6.24
  • Average True Range (ATR)
  • HAE 1.22
  • MQ 0.14
  • MACD
  • HAE 0.33
  • MQ -0.06
  • Stochastic Oscillator
  • HAE 11.20
  • MQ 3.48

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About MQ Marqeta Inc.

Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.

Share on Social Networks: